The global Parkinson’s disease drug market is anticipated to grow at a CAGR of over 6% during the forecast period. Parkinson’s disease is a progressive nervous system disorder. Parkinson’s disease affects the movement of the body and the symptoms start gradually. In some cases, symptoms start with a barely noticeable tremor in just one hand and go further to affect other parts. Along with tremors, Parkinson’s disease also commonly causes stiffness or slowing of movement in patients.




Get Free Sample Copy @ https://www.omrglobal.com/request-sample/parkinsons-disease-drug-market



The global Parkinson’s disease drug market is segmented on the basis of the drug class into dopamine receptor agonists, MAO-inhibitors, carbidopa-levodopa, catechol O-methyltransferase (COMT) inhibitors, anticholinergics, and others. The other subsegment includes amantadine and selegiline.



Secondary Sources Include:

· Financial reports of companies involved in the market

· Whitepapers research-papers, and news blogs

· Company websites and their product catalogue



The report is intended for a healthcare service provider, medical device companies, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.



A Full Report of Global Parkinson’s Disease Drug Marketis Available at: https://www.omrglobal.com/industry-reports/parkinsons-disease-drug-market







Market Overview and Insights

l Scope of the Report

l Analyst Insight & Current Market Trends

l Key Findings

l Recommendations

l Conclusion

l Rules & Regulations

Market Segmentation

l Global Parkinson’s Disease Drugs Market by Drug Class

l Dopamine Receptor Agonists

l MAO-Inhibitors

l Carbidopa-Levodopa

l Catechol O-methyltransferase (COMT) Inhibitors

l Anticholinergics

l Others(Amantadine, Selegiline)





Company Profiles

l AbbVie Inc.

l ACADIA Pharmaceuticals Inc.

l Apotex Inc.

l Axovant Gene Therapies Ltd.

l Boehringer Ingelheim GmbH

l Bausch Health Companies Inc.

l Boston Scientific Corp.

l Cipla Inc.

l Daiichi Sankyo Espha Co., Ltd.

l Eli Lilly & Co.

l Eisai Co., Ltd.

l F. Hoffmann-La Roche AG

l GlaxoSmithKline Plc

l Impax Laboratories, Inc.

l Merck & Co. Inc.

l Mylan NV

l Novartis International AG

l Orion Corp.

l Pfizer Inc.

l Sanofi SA

l Teva Pharmaceutical Industries Ltd.

l Vertical Pharmaceuticals, LLC

l Wockhardt Ltd.



Regional Analysis

North America

l United States

l Canada

Europe

l UK

l Germany

l Italy

l Spain

l France

l Rest of Europe

Asia-Pacific

l China

l India

l Japan

l Rest of Asia-Pacific

l Rest of the World



Global Parkinson’s Disease Drug Market– Segment by Region

North America

· United States

· Canada

Europe

· Germany

· United Kingdom

· France

· Spain

· Italy

· Rest of Europe

Europe

· North-American

· Japan

· India

· Rest of North-American

Rest of the World

· Latin America

· Middle East and Africa



For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/parkinsons-disease-drug-market



About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404